How many clinical trials are tracked of ibrexafungerp?

6 trials are tracked, 2 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Urology Dermatology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

ibrexafungerp

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of ibrexafungerp

6 trials tracked of ibrexafungerp: 5 in phase 3 or 4 and 2 with published results. The most-cited published study has 23 citations.

6Trials tracked

5Phase 3 & 4

0Recruiting

2With published results

Phase distribution

Phase 3 5 Phase 1 1

Phase 3 Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis (VANISH 303) Completed · 23 cited
Phase 3 Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis Completed · 23 cited
Phase 3 Phase 3 Study of Oral Ibrexafungerp (SCY-078) Vs. Placebo in Subjects With Recurrent Vulvovaginal Candidiasis (VVC) Completed
Phase 3 Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis Completed
Phase 3 Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment Completed
Phase 1 Pharmacokinetic Study in Healthy Lactating Women Exposed to Ibrexafungerp Completed

Showing the 6 most-cited and recently-updated of 6 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.